Prof Calvo is the Director of START Madrid Group in Madrid (Early Phase Clinical Drug Development in Oncology, international programme) and has been the Director of Clinical Research at the START Madrid-Centro Integral Oncológico Clara Campal hospital, in Madrid, Spain, since its launch in 2008. He is also the President of the Investigational Therapeutics in Oncological Sciences Foundation (Intheos). In addition, he is an Associate Professor at University CEU San Pablo in Madrid, Spain.
Prof Calvo has co-authored approximately one hundred publications, including scientific articles, chapters in oncology books and presentations at different major conferences and meetings, especially focusing on clinical development of new drugs in different tumor types. He serves as an ad-hoc reviewer of various oncology journals, and has recently been appointed board editor for European Journal of Cancer and Investigational New Drugs. He is a panel expert advisor at multiple Advisory Boards of anticancer drug development and disease-specific cancer therapeutics. During the last 12 years of almost full dedication to Clinical Drug development in Oncology, he has participated in around two hundred international studies, as a clinical investigator, especially in Early Clinical Drug Development.